|
![]() |
|||
|
||||
OverviewThis book assembles recent achievements in both basic research and clinical management in the field of hepatology, virology and immunology. It provides up-to-date information for clinicians who can apply the relevant knowledge to their daily clinical practice and for researchers who are interested in clinically orientated studies. The updated and detailed technology, state-of–the-art treatment strategies provided in this book serve as references for clinicians and resident physicians in the daily management of ACLF. The rationality and strategies for basic research as well as patient management in this book can also be a valuable reference for other fatal and end stage liver diseases than HBV induced ACLF. This volume 1 has 6 chapters and focuses on the definition, research technology, virology, genetics, and immunology. Full Product DetailsAuthor: Qin NingPublisher: Springer Imprint: Springer Edition: 1st ed. 2019 Weight: 0.926kg ISBN: 9789402416046ISBN 10: 9402416048 Pages: 369 Publication Date: 27 May 2019 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationEditor Qin Ning is a Professor and Director of the Deptartment of Infectious Disease, Tongji Hospital, Wuhan, China. Tab Content 6Author Website:Countries AvailableAll regions |